Le cancer ne prend pas de vacances: Le #DIPG a pris la vie de Lily ce 25 juillet. Elle s’est battue si vaillamment depuis décembre 2024. Elle aura 13 ans pour l’éternité! Un véritable héros ( comme Lily ) ne se mesure pas à sa force physique, mais à la force de son cœur !

ICYMI: Finally some good news! The senate committee rejected the 40% budget cut for NIH and instead endorsed a $400 million budget increase! Science for the win.

Please read our newest edition in August 2025! #JNO See more here:

We’re proud to announce that our Co-founder and former Chief Executive, Sue Farrington Smith MBE MBE, is stepping into a new chapter with Brain Tumour Research as our Ambassador. Sue’s journey started with heartbreak. In 2001, her beloved niece Alison Phelan died from a brain stem glioma,

The countdown to Childhood Cancer Awareness Month is ON—just 31 days to go! 💛 All month long we’ll share ways to #GoGold, fundraise, raise awareness & support families affected by childhood cancer. Let’s GO GOLD® this September for kids!

'Integrating and interpreting brain maps' Review article by Justine Hansen & Bratislav Misic cell.com/trends/neurosc…

Online Now: Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications dlvr.it/TMF9YN

Seattle Children’s provides the most advanced treatments and clinical trials for children, teens and young adults with cancer of any pediatric hospital in the Pacific Northwest. At Seattle Children’s, doctors, nurses, therapists, social workers and many more dedicated people

Shen et al. revealed that CCDC34 functions as an oncogene in lower-grade gliomas, with high expression linked to poor prognosis. Targeting CCDC34 may offer therapeutic potential by disrupting key oncogenic pathways like PI3K-Akt and Notch. #JNO Read more:link.springer.com/article/10.100…

🚨 Abstracts for our annual meeting in Philadelphia "Neuropsychology in the Age of Innovation" are due at the end of THIS month! Submit a poster or paper here bit.ly/3FBcrAp or a symposium here bit.ly/4l7s8OP by August 29th 🧠 more info buff.ly/llC61sK

We know that as caregiver to someone living with a #braintumor, looking after your own well-being can easily fall to the bottom of the list, but small acts of self-care can make a difference. Share your self-care tips as a care partner with NBTS: braintumor.org/brain-tumors/s…

Behind the Science: New tools reveal how ribosomes — the cell’s protein factories — specialize in ways that could unlock treatments for cancer, neurodegenerative diseases, and more. Maria Barna and team are digging deep. stan.md/3H9xScq

Collection highlight from Cancer Cell: Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy hubs.li/Q03x0gSB0 Penn Medicine

On Saturday 27th September, or any day that suits you this September, lace up your shoes and join thousands across the UK taking steps towards a cure for brain tumours. How to get involved: 👟 Join one of our flagship Walk of Hope events 👪 Or organise your own wherever you

Are you a patient with a #braintumor and/or a #carepartner interested in joining a research study? NBTS #QualityofLife Research Grant recipients Dr. Ashlee Loughan, PhD 🧠, PhD, and Dr. Sarah Ellen Braun, PhD, PhD, are seeking participants for their FearLess in Neuro-Oncology intervention.

Compensation is available. If you are interested in participating in this #braintumor #qualityoflife research study, please call or email the researchers directly to see if you are eligible: (804) 628-6799 or [email protected] LiveNOWLab

Could the same proteins that drive autoimmune disease help fight cancer? In nature, Emerging Leader Award winner Aaron Ring of @FredHutch shows that some autoantibodies are linked to better outcomes for patients receiving checkpoint inhibitor therapies. fredhutch.org/en/news/releas…

Turan et al. identified GAL-8, ITGβ-1, and HIF-1α as promising non-invasive serum biomarkers for glioma diagnosis and prognosis, with higher levels associated with tumor grade progression and angiogenesis. #JNO Read more:link.springer.com/article/10.100…

Our synthesis of 28 ongoing cell-based trials, a strategic pivot: immune-engineered CAR-T, NK, and APC platforms now target EGFRvIII, B7-H3, CD70, while co-opting stem cell vectors to bypass TME barriers & restore anti-tumor immunity Vratko Himič Journal of Neuro-Oncology link.springer.com/article/10.100…

🎉 Huge congrats to our ED Nursing Team! They've won the 2025 Lantern Award from ENA! This the fourth consecutive round the ENA has recognized their dedication & compassionate care. Join us in celebrating these incredible nurses! 🙌 #Nursing #Gratitude